Microbot Medical Inc. short interest in 2025
In 2025, Microbot Medical Inc.'s disclosed short interest ran from 10.65% of shares outstanding on 15 Jan 2025 to 10.52% on 31 Dec 2025, a change of -0.13 percentage points. The year's high was 30.27% on 14 Mar 2025 and its low 6.90% on 14 Nov 2025, averaging 17.89% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.60 days on 30 Jun 2025. Full history: Microbot Medical Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 10.65% (15 Jan 2025)
- End of year
- 10.52% (31 Dec 2025)
- Change
- -0.13 pp
- High
- 30.27% (14 Mar 2025)
- Low
- 6.90% (14 Nov 2025)
- Average
- 17.89%
- Highest days to cover
- 8.60 (30 Jun 2025)
- SEC filings marked
- 4
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 10.65% | 1.00 | |
| 31 Jan 2025 | 24.63% | 1.19 | |
| 14 Feb 2025 | 28.09% | 1.00 | |
| 28 Feb 2025 | 29.65% | 2.65 | |
| 14 Mar 2025 | 30.27% | 6.61 | |
| 31 Mar 2025 | 15.61% | 5.71 | 10-K filed |
| 15 Apr 2025 | 15.89% | 1.00 | |
| 30 Apr 2025 | 18.44% | 2.35 | |
| 15 May 2025 | 19.50% | 4.79 | 10-Q filed |
| 30 May 2025 | 22.62% | 3.78 | |
| 13 Jun 2025 | 23.19% | 4.55 | |
| 30 Jun 2025 | 22.78% | 8.60 | |
| 15 Jul 2025 | 22.90% | 7.03 | |
| 31 Jul 2025 | 23.43% | 2.98 | |
| 15 Aug 2025 | 16.99% | 4.32 | 10-Q filed |
| 29 Aug 2025 | 16.43% | 1.71 | |
| 15 Sep 2025 | 23.33% | 1.13 | |
| 30 Sep 2025 | 9.96% | 1.00 | |
| 15 Oct 2025 | 9.28% | 1.31 | |
| 31 Oct 2025 | 9.55% | 1.73 | |
| 14 Nov 2025 | 6.90% | 2.38 | 10-Q filed |
| 28 Nov 2025 | 9.25% | 1.78 | |
| 15 Dec 2025 | 9.56% | 2.39 | |
| 31 Dec 2025 | 10.52% | 4.94 |
See also: Microbot Medical Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.